AXS-05 (dextromethorphan-bupropion)
AXS-05-AD-303
Phase 3 small_molecule completed
Quick answer
AXS-05 (dextromethorphan-bupropion) for Agitation in Patients With Dementia of the Alzheimer's Type is a Phase 3 program (small_molecule) at Axsome Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Agitation in Patients With Dementia of the Alzheimer's Type
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed